Artificial Intelligence (AI) in Healthcare Market

Based on offerings, the market is segmented into integrated solutions, niche/point solutions, AI technologies, and services. In 2025, integrated solutions held the largest share due to the growing need for interoperability and seamless data sharing in the healthcare sector to improve administrative and healthcare provision management processes. The preference by healthcare organizations for integrated software that integrates electronic health records (EHR), revenue cycle management, imaging, patient engagement, and analytics platforms to create an ecosystem has increased significantly. An integrated system also simplifies IT operations and ensures that healthcare organizations adopt a value-based approach. For example, in May 2026, Fujitsu and IBM Japan partnered to create a sovereign cloud that facilitates the integration and application of artificial intelligence in the management of healthcare data across multiple healthcare facilities.

Based on function, the market is segmented into diagnosis & early detection, treatment planning & personalization, patient engagement & remote monitoring, post-treatment surveillance & survivorship care, pharmacy management, data management & analytics, AI Scribe, CDSS, and administrative functions. In 2025, diagnosis & early detection held the largest share due to the growing use of artificial intelligence-based technologies in medical imaging, disease diagnosis, risk assessment, and clinical decision-making. The use of AI-based algorithms helps healthcare professionals detect diseases at an early stage, enhance diagnostic accuracy, reduce the time required to interpret images, and make prompt decisions about intervention. The rise in the prevalence of chronic diseases, the growing need for personalized medicine, and the use of AI in medical specialties such as radiology, pathology, cardiology, and oncology are also expected to fuel segment growth. For instance, in April 2026, the European Commission launched programs to fund pilot projects that use AI in medical imaging.

Based on applications, the market is segmented into clinical applications and non-clinical applications. In 2025, clinical applications accounted for the largest share due to the rising use of artificial intelligence (AI)-based technologies in medical diagnostics, healthcare imaging, clinical decision-making, medical prognosis, treatment planning, and patient monitoring. Healthcare organizations are using AI technology to provide accurate diagnoses, make evidence-based medical decisions, and improve treatment outcomes while reducing the burden on clinicians. Other factors such as the rising incidence of chronic diseases and the need for personalized medicines are also driving the market’s expansion.

Based on deployment models, the market is segmented into on-premise, cloud-based, and hybrid models. Cloud-based deployments held the largest share, driven by their scalability, affordability, flexibility, and capabilities that allow for storing and processing vast amounts of healthcare information. Cloud computing enables healthcare companies to quickly implement AI applications, provide immediate access to data, promote interoperability, and collaborate more effectively across healthcare networks. The growing use of EHRs, telehealth platforms, remote patient monitoring tools, and advanced AI-powered analytics software has driven demand for cloud-based healthcare infrastructure.

Based on tools, the market is segmented into machine learning, natural language processing, context-aware computing, generative AI, computer vision, and image analysis. In 2025, machine learning accounted for a significant share, driven by its broad applications in medical imaging, disease diagnosis, clinical decision-making, predictive analytics, drug discovery, and personalized medicine. By applying machine learning approaches, healthcare companies can analyze large, complex data, identify patterns, predict disease risk, and make data-driven decisions that improve their effectiveness and patients' health. Machine learning technologies' ability to continually learn from new information and develop prediction algorithms enables their wide application across all kinds of healthcare projects. For example, in February 2026, the US Department of Health and Human Services' ARPA-H announced the launch of the Intelligent Generator of Research (IGoR) program, which uses AI techniques to accelerate research and disease modeling.

Based on end users, the market is segmented into healthcare providers, healthcare payers, patients, and other end users. In 2025, healthcare providers held the largest share as more AI-driven innovations are deployed for diagnostics, medical imaging, clinical decision support, patient monitoring, workflow management, and clinical documentation purposes. Healthcare institutions are increasingly adopting AI technologies to improve their operations and provide more accurate diagnoses. The rising volume of health-related information, the growing prevalence of chronic conditions, and the emphasis on value-based care practices are all contributing to the increasing adoption of AI in the healthcare sector. For example, in February 2026, M Health Fairview opted for Nabla’s Ambient AI Assistant and Dictation to deploy them systemwide across its network.